SCHEMBL132267

SCHEMBL132267

ClC1CC1.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495 0.94
SCHEMBL2764664 0.94
SCHEMBL9720381 0.88
SCHEMBL20993361 0.88
Ammonia Solution, Strong SCHEMBL27795187 0.88
SCHEMBL1716583 0.88
SCHEMBL1445938 0.88
Lindane SCHEMBL10694454 0.82 LMNA (0.56)
Hydrazine SCHEMBL22043002 0.78
SCHEMBL9416085 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010689-A Preparation method of cycloparaffin 浙江清华长三角研究院 2026-05-12 CN claimed
CN-119462520-A Preparation method of substituted benzoate derivative 上海皓元医药股份有限公司 2025-02-18 CN claimed
CN-117024354-B Preparation method of Rui Mi Buti Ni 天津凯莱英制药有限公司 2023-12-08 CN claimed
CN-117024354-A Preparation method of Rui Mi Buti Ni 天津凯莱英制药有限公司 2023-11-10 CN claimed
CN-113105335-B Synthetic method of stable deuterium-labeled melitracen hydrochloride 梯尔希(南京)药物研发有限公司 2022-03-18 CN claimed
CN-113105335-A Synthetic method of stable deuterium-labeled melitracen hydrochloride 梯尔希(南京)药物研发有限公司 2021-07-13 CN claimed
CN-122010689-A Preparation method of cycloparaffin 浙江清华长三角研究院 2026-05-12 CN disclosed
US-20250214994-A1 PROCESS FOR THE PREPARATION OF PALBOCICLIB ALIVUS LIFE SCIENCES LIMITED (IN) 2025-07-03 US disclosed
CN-119462520-A Preparation method of substituted benzoate derivative 上海皓元医药股份有限公司 2025-02-18 CN disclosed
EP-4504727-A1 PROCESS FOR THE PREPARATION OF PALBOCICLIB Alivus Life Sciences Limited (IN) 2025-02-12 EP disclosed
US-20240247015-A1 PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2024-07-25 US disclosed
EP-4322962-A1 PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS Bayer Aktiengesellschaft (DE) 2024-02-21 EP disclosed
CN-117500507-A Phosphorus derivatives as novel SOS1 inhibitors 拜耳公司 2024-02-02 CN disclosed
EP-1781649-A2 SUBSTITUTED HYDANTOINS F. Hoffmann-Roche AG (CH) 2007-05-09 EP disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 US disclosed
US-20060041146-A1 Substituted hydantoins HOFFMANN-LA ROCHE AG 2006-02-23 US disclosed
WO-2006018188-A2 SUBSTITUTED HYDANTOINS F. HOFFMANN-LA ROCHE AG (CH) 2006-02-23 WO disclosed
WO-2006020830-A2 BISARYL-SULFONAMIDES AMGEN INC. (US) 2006-02-23 WO disclosed
EP-1007515-A1 ARYLPYRIDAZINONES AS PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS Abbott Laboratories (US) 2000-06-14 EP disclosed
WO-1999010331-A1 ARYLPYRIDAZINONES AS PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-03-04 WO disclosed